Root (ROOT) had the highest return between February 12, 2024 and February 26, 2024 by a mid-cap US stock, returning 199.1%.
| ASSET | DATE | % RETURN |
|---|---|---|
Root (ROOT) | 2/12/2024 - 2/26/2024 | 199.08% |
SoundHound AI (SOUN) | 2/12/2024 - 2/26/2024 | 153.3% |
D-Wave Quantum (QBTS) | 2/12/2024 - 2/26/2024 | 58.33% |
PureCycle Technologies (PCTTW) | 2/12/2024 - 2/26/2024 | 48.48% |
Recursion Pharmaceuticals (RXRX) | 2/12/2024 - 2/26/2024 | 45.71% |
CleanSpark (CLSK) | 2/12/2024 - 2/26/2024 | 43.41% |
Rigetti Computing (RGTI) | 2/12/2024 - 2/26/2024 | 43.08% |
Krystal Biotech (KRYS) | 2/12/2024 - 2/26/2024 | 40.18% |
Pegasystems (PEGA) | 2/12/2024 - 2/26/2024 | 29.71% |
Advantage Solutions (ADVWW) | 2/12/2024 - 2/26/2024 | 28.53% |
Intercorp Financial Services (IFS) | 2/12/2024 - 2/26/2024 | 27.38% |
Cellebrite DI (CLBT) | 2/12/2024 - 2/26/2024 | 27.1% |
Shake Shack (SHAK) | 2/12/2024 - 2/26/2024 | 26.9% |
Freshpet (FRPT) | 2/12/2024 - 2/26/2024 | 25.88% |
Lufax (LU) | 2/12/2024 - 2/26/2024 | 24.9% |
Sylvamo (SLVM) | 2/12/2024 - 2/26/2024 | 24.56% |
Resideo Technologies (REZI) | 2/12/2024 - 2/26/2024 | 23.68% |
Medpace (MEDP) | 2/12/2024 - 2/26/2024 | 23.56% |
Mercury General (MCY) | 2/12/2024 - 2/26/2024 | 23.31% |
Blueprint Medicines (BPMC) | 2/12/2024 - 2/26/2024 | 23.09% |
Palomar (PLMR) | 2/12/2024 - 2/26/2024 | 22.94% |
Crispr Therapeutics (CRSP) | 2/12/2024 - 2/26/2024 | 22.89% |
Viking Therapeutics (VKTX) | 2/12/2024 - 2/26/2024 | 22.78% |
SS Innovations International Inc Common Stock (SSII) | 2/12/2024 - 2/26/2024 | 22.73% |
LYFT (LYFT) | 2/12/2024 - 2/26/2024 | 22.22% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
